US › Healthcare

High Tide Inc (HITI)

US · Healthcare · Pharmaceutical Retailers

$2.65-1.49%

Last close · 2026-09-17

Latest quarter · ended 2026-07-31

Revenue

$201.0M

Revenue YoY

+34.3%

Net profit

$11.4M

Profit YoY

+1809.0%

EPS

$0.02

EPS estimate

$0.01

Net margin

5.7%

EPS came in at 0.02 against a street estimate of 0.01 — a beat of 100.0%.

Key statistics

Market cap

$239.8M

Forward P/E

18.7

P/B

3.57

Book value

$0.87

EPS (TTM)

$-0.41

52-week high

$4.06

52-week low

$2.02

50-day MA

$2.34

200-day MA

$2.43

Beta

1.08

Analyst view

Analysts rate High Tide Inc a strong buy (5 buy, 0 hold, 0 sell out of 5) with an average price target of $4.67.

Shareholding

Insiders

12.19%

Institutions

8.79%

Largest institutional holders

Fund	Stake
Tidal Investments LLC.	1.95%
AdvisorShares Investments, LLC	1.34%
Renaissance Technologies Corp	1.22%
Two Sigma Investments LLC	0.75%
Bank of America Corp	0.39%
Walleye Trading Advisors, LLC	0.35%
Federation des caisses Desjardins du Quebec	0.29%
Baader Bank INC	0.28%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for High Tide Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.